BW THERAPEUTICS
Founded in 2019 as a biotechnology company focused on the development of TYN-21, a 505(b)(2) formulation of Abraxane.
BW THERAPEUTICS
Social Links:
Industry:
Biotechnology
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.bwtherapeutics.com
Status:
Closed
Technology used in webpage:
SPF SAKURA Internet
Similar Organizations
Suvica
Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.bwtherapeutics.com
Unable to get host informations!!!
More informations about "BW Therapeutics"
BlossomHill Therapeutics - Crunchbase Company …
Contact Email [email protected] BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. Products and ServicesSee details»
About | BlossomHill Therapeutics
May 28, 2024 Dr. J. Jean Cui has a prolific track record as a cancer drug designer and developer. Three molecules designed by Dr. Cui have become market-approved medicines, including repotrectinib (AUGTYRO ®), crizotinib …See details»
Home | BlossomHill Therapeutics
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here.See details»
BlossomHill Therapeutics, Inc. | LinkedIn
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.See details»
BlossomHill Therapeutics - PitchBook
Www.bhtherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 3525 John Hopkins Court; Suite 100; San Diego, CA 92121; United StatesSee details»
BlossomHill Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BlossomHill Therapeutics, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
BlossomHill Therapeutics - VentureRadar
"BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.See details»
BlossomHill Therapeutics Chief Executive Officer, Jingrong Jean …
SAN DIEGO, February 14, 2024--BlossomHill Therapeutics, a biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune …See details»
Clinical Trials | BlossomHill Therapeutics
If you have any questions about our investigational drugs or clinical trials, please contact [email protected]. Timing of Acknowledgment BlossomHill Therapeutics, Inc. …See details»
Series B - BlossomHill Therapeutics - 2024-01-02 - Crunchbase
Jan 2, 2024 Organization Name . BlossomHill Therapeutics . Announced Date Jan 2, 2024; Closed On Date Feb 29, 2024; Funding Type Series B; Funding Stage Early Stage Venture; …See details»
BlossomHill Therapeutics Chief Executive Officer
Feb 14, 2024 SAN DIEGO--(BUSINESS WIRE)--BlossomHill Therapeutics, a biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, today …See details»
Blossomhill Therapeutics - Overview, News & Similar ... - ZoomInfo
Blossomhill Therapeutics contact info: Phone number: (858) 732-3880 Website: www.bhtherapeutics.com What does Blossomhill Therapeutics do? Blossomhill Therapeutics …See details»
BlossomHill Therapeutics Chief Executive Officer, Jingrong
Feb 14, 2024 SAN DIEGO--(BUSINESS WIRE)-- BlossomHill Therapeutics, a biotechnology company focused on the design and development of small molecule medicines for treating …See details»
BlossomHill Therapeutics Chief Executive Officer ... - Business Wire
Feb 14, 2024 SAN DIEGO--(BUSINESS WIRE)--BlossomHill Therapeutics, a biotechnology company focused on the design and development of small molecule medicines for treating …See details»
Terms of Service | BlossomHill Therapeutics
You have the right to opt-out and not be bound by the arbitration provisions set forth in these Terms by sending written notice of your decision to opt-out to [email protected]. The …See details»
BlossomHill Therapeutics Closes $100 Million Series B Financing
SAN DIEGO, Calif., February 29, 2024--BlossomHill Therapeutics, Inc., a biotechnology company focused on the design and development of small molecule medicines for treating cancer and …See details»
BlossomHill Therapeutics Closes $100 Million Series B Financing
Feb 29, 2024 SAN DIEGO, Calif.--(BUSINESS WIRE)-- BlossomHill Therapeutics, Inc., a biotechnology company focused on the design and development of small molecule medicines …See details»
BlossomHill Therapeutics Closes $71M Series A Financing
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a biopharmaceutical company focusing on oncology and autoimmune disorders, announced …See details»
Careers | BlossomHill Therapeutics
We are a science-forward organization led by our luminary, Dr. Jean Cui, and we welcome all to traverse mountains, ridges, rivers and streams to BlossomHill and solve treatment resistance. …See details»
Pipeline | BlossomHill Therapeutics
We are evaluating a potentially better way to treat EGFR-positive NSCLC. BH-30643 is a mutant-selective OMNI-EGFR â„¢ inhibitor with an aim to provide greater benefit to patients by:. Super …See details»